ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
5.83
+0.16 (2.82%)
At close: Jul 29, 2026, 4:00 PM EDT
5.82
-0.01 (-0.17%)
Pre-market: Jul 30, 2026, 7:09 AM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $578.94 million as of July 30, 2026. Its market cap has decreased by -67.88% in one year.
Market Cap
578.94M
Enterprise Value
549.16M
1-Year Change
-67.88%
Ranking
Category
Stock Price
$5.83
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $578.94M, an increase of 1.88%. That is a compound annual growth rate of 0.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 578.94M | -49.73% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 604.02M |
| REGENXBIO | 599.13M |
| CorMedix | 596.23M |
| Tectonic Therapeutic | 577.59M |
| Altimmune | 575.64M |
| Zevra Therapeutics | 574.01M |
| Silence Therapeutics | 570.11M |
| Relmada Therapeutics | 545.43M |